Maintenance treatment with thalidomide after autologous transplantation for myeloma:: Final analysis of a prospective randomized study of the "Intergroupe Francophone du Myelome".

被引：0
|
作者：
Attal, M [1 ]
Harousseau, JL [1 ]
Leyvraz, S [1 ]
Doyen, C [1 ]
Hulin, C [1 ]
Benboubker, L [1 ]
Agha, IY [1 ]
Bourhis, JH [1 ]
Garderet, L [1 ]
Sotto, JJ [1 ]
Michallet, M [1 ]
Renaud, M [1 ]
Voillat, L [1 ]
Berthou, C [1 ]
Marit, G [1 ]
Monconduit, M [1 ]
Dumonté, C [1 ]
Caillot, D [1 ]
Mathiot, C [1 ]
Avet-Loiseau, H [1 ]
机构：
[1] Hop Purpan, Hematol Serv, Toulouse, France
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1148
引用
收藏
页码：335A / 335A
页数：1
相关论文
共 50 条
  • [41] Successful treatment of multiple myeloma relapsing after high-dose therapy and autologous transplantation with thalidomide as a single agent
    A Zomas
    N Anagnostopoulos
    MA Dimopoulos
    Bone Marrow Transplantation, 2000, 25 : 1319 - 1320
  • [42] Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant
    Stewart, AK
    Chen, CI
    Howson-Jan, K
    White, D
    Roy, J
    Kovacs, MJ
    Shustik, C
    Sadura, A
    Shepherd, L
    Ding, K
    Meyer, RM
    Belch, AR
    CLINICAL CANCER RESEARCH, 2004, 10 (24) : 8170 - 8176
  • [43] Optimal treatment strategies in myeloma: An argument against maintenance therapy after autologous stem cell transplantation
    Richter, Joshua
    Biran, Noa
    Vesole, David
    Siegel, David
    SEMINARS IN ONCOLOGY, 2016, 43 (06) : 714 - 717
  • [44] Limite d b enefits of thalidomide and dexamethasone maintenance after autologous stem cell transplantation in newly diagnosed multiple myeloma patients: a prospective phase II multi-center study in Korea
    Byun, Ja Min
    Kim, Sang-A
    Koh, Youngil
    Shin, Dong-Yeop
    Kwon, Ji Hyun
    Kim, Jin Seok
    Kim, Kihyun
    Min, Chang-Ki
    Eom, Hyeon-Seok
    Lee, Je-Jung
    Bang, Soo-Mee
    Yoon, Sung-Soo
    CURRENT PROBLEMS IN CANCER, 2022, 46 (01)
  • [45] Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis
    Pasvolsky, Oren
    Yeshurun, Moshe
    Fraser, Raphael
    Estrada-Merly, Noel
    Rozovski, Uri
    Shargian-Alon, Liat
    Assal, Amer
    Banerjee, Rahul
    Bumma, Naresh
    Gale, Robert Peter
    Hagen, Patrick
    Holmberg, Leona
    Hossain, Nasheed M.
    Lazarus, Hillard M.
    Lee, Cindy
    Mian, Hira
    Miller, Kevin C.
    Nathan, Sunita
    Nagler, Arnon
    Nishihori, Taiga
    Parrondo, Ricardo D.
    Patel, Sagar
    Schroeder, Mark A.
    Usmani, Saad Z.
    Wang, Trent
    Wirk, Baldeep
    Kumar, Shaji
    Shah, Nina
    Qazilbash, Muzaffar H.
    D'Souza, Anita
    BONE MARROW TRANSPLANTATION, 2022, 57 (01) : 31 - 37
  • [46] Twice Weekly Induction with Ixazomib-Lenalidomide-Dexamethasone (IRd) Combination Followed By Extended IRD Consolidation and Lenalidomide Maintenance in Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma (NDMM): A Phase 2 Study from the Intergroupe Francophone Du Myelome (IFM 2014-03)
    Roussel, Murielle
    Hebraud, Benjamin
    Hulin, Cyrille
    Leleu, Xavier
    Facon, Thierry
    Boyle, Eileen
    Touzeau, Cyrille
    Pegourie, Brigitte
    Perrot, Aurore
    Stoppa, Anne-Marie
    Marolleau, Jean-Pierre
    Moreau, Philippe
    Avet-Loiseau, Herve
    Devlamynck, Laure
    Lauwers-Cances, Valerie
    Attal, Michel
    BLOOD, 2019, 134
  • [47] Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis
    Oren Pasvolsky
    Moshe Yeshurun
    Raphael Fraser
    Noel Estrada-Merly
    Uri Rozovski
    Liat Shargian-Alon
    Amer Assal
    Rahul Banerjee
    Naresh Bumma
    Robert Peter Gale
    Patrick Hagen
    Leona Holmberg
    Nasheed M. Hossain
    Hillard M. Lazarus
    Cindy Lee
    Hira Mian
    Kevin C. Miller
    Sunita Nathan
    Arnon Nagler
    Taiga Nishihori
    Ricardo D. Parrondo
    Sagar Patel
    Mark A. Schroeder
    Saad Z. Usmani
    Trent Wang
    Baldeep Wirk
    Shaji Kumar
    Nina Shah
    Muzaffar H. Qazilbash
    Anita D’Souza
    Bone Marrow Transplantation, 2022, 57 : 31 - 37
  • [48] Thalidomide as rescue of relapses after haematopoietic transplantation in multiple myeloma and as maintenance treatment:: Results of a Spanish multicentre study including 63 patients.
    Alegre, A
    Gil-Fernández, JJ
    Font, P
    Alonso, A
    Sureda, A
    Martínez-Chamorro, C
    Escudero, A
    Sánchez-Godoy, P
    Burgaleta, C
    Casado, LF
    Granda, A
    Aguado, B
    Osorio, S
    Nistal, S
    Mascuñano, R
    Prieto, E
    Fernández-Rañada, JM
    BLOOD, 2002, 100 (11) : 390B - 390B
  • [49] Multiple myeloma treatment at relapse after autologous stem cell transplantation: A practical analysis
    Malard, F.
    Harousseau, J. L.
    Mohty, M.
    CANCER TREATMENT REVIEWS, 2017, 52 : 41 - 47
  • [50] Thalidomide plus dexamethasone as a maintenance therapy after autologous hematopoietic stem cell transplantation improves progression-free survival in multiple myeloma
    Maiolino, Angelo
    Hungria, Vania T. M.
    Garnica, Marcia
    Oliveira-Duarte, Gislaine
    Oliveira, Luciana C. O.
    Mercante, Daniel R.
    Miranda, Eliana C.
    Quero, Adriana A.
    Peres, Ana L. M.
    Barros, Jose C.
    Tanaka, Paola
    Magalhaes, Roberto P.
    Rego, Eduardo M.
    Lorand-Metze, Irene
    Lima, Carmen S. P.
    Renault, Ilana Z.
    Braggio, Esteban
    Chiattone, Carlos
    Nucci, Marcio
    de Souza, Carmino A.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (10) : 948 - 952
12345